Bristol Myers Squibb CEO Giovanni Caforio credited COVID-19-related stocking for high sales of some products in the first […]
Biogen has had a rocky road with its controversial Alzheimer’s disease candidate aducanumab, resurrected late last year. But […]
With its multibillion-dollar restructuring plan in the rearview mirror, Teva is pinning its future growth on two of […]
Global coronavirus vaccine makers have been rolling out details about their manufacturing and launch plans—even ahead of any […]
Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling […]
More than four months after the first cases in China, we know a lot about covid-19. But much […]
AbstractObjectiveTo evaluate the prognosis of unrecognised myocardial infarction determined by electrocardiography (UMI-ECG) or cardiac magnetic resonance imaging (UMI-CMR).DesignSystematic […]
Dementia, benzodiazepines, and Z-drugsA longitudinal study of a quarter of a million adults in Denmark who had an […]
The UK’s decision to stop community testing and contact tracing for covid-19 in early March was partly driven […]
AbstractObjectiveTo examine changes in categories of soft drink consumption in a cohort of Mexican adults, three years after […]